您的位置: 专家智库 > >

国家自然科学基金(30200343)

作品数:6 被引量:14H指数:2
相关作者:向明邹晓蕾曹瑜袁思佑张程亮更多>>
相关机构:华中科技大学更多>>
发文基金:国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 5篇期刊文章
  • 2篇会议论文

领域

  • 7篇医药卫生

主题

  • 5篇糖尿
  • 5篇糖尿病
  • 3篇细胞
  • 3篇小鼠
  • 3篇免疫
  • 3篇1型糖尿病
  • 2篇糖尿病小鼠
  • 2篇自身抗原
  • 2篇抗原
  • 2篇T细胞
  • 2篇1型糖尿病小...
  • 2篇DENDRI...
  • 2篇AUTOAN...
  • 1篇动物
  • 1篇动物模型
  • 1篇胰岛
  • 1篇胰岛素
  • 1篇胰岛素皮下注...
  • 1篇树突
  • 1篇树突状

机构

  • 4篇华中科技大学

作者

  • 4篇向明
  • 3篇张程亮
  • 2篇袁思佑
  • 2篇曹瑜
  • 2篇邹晓蕾
  • 1篇汤静
  • 1篇彭佳蓓
  • 1篇储潼
  • 1篇蔡晓寒
  • 1篇李秋

传媒

  • 1篇中华微生物学...
  • 1篇医药导报
  • 1篇中国药师
  • 1篇Chines...
  • 1篇Journa...

年份

  • 1篇2008
  • 2篇2007
  • 4篇2006
6 条 记 录,以下是 1-7
排序方式:
自身抗原胰岛素皮下注射诱导1型糖尿病模型小鼠的免疫耐受作用被引量:2
2006年
目的探讨自身抗原诱导免疫耐受防治1型糖尿病(IDDM)的方法及机制。方法将32只8周龄BALB/c小鼠随机分为4组:空白对照组、模型对照组、皮下注射给药组和灌胃给药组,各8只。各组小鼠每日腹腔注射链脲佐菌素(STZ)40 mg.kg-1,连续5 d,建立IDDM模型。皮下注射给药组于造模前1 d每只皮下注射胰岛素100μg,以后每周给药1次,连续4周。灌胃给药组于造模前1 d每只灌胃给予胰岛素150μg,以后每周给药2次,连续4周。每周测定血糖值。6周后处死小鼠,取胰腺组织HE染色观察胰岛组织变化,四唑盐比色法(MTT法)测定小鼠脾淋巴细胞增殖反应。另取脾细胞采用荧光激活细胞分类技术(FACS)分析CD4+CD2+5T细胞亚群比例。结果与模型对照组比较,皮下注射给药组血糖值明显降低(P<0.05),而灌胃给药组则差异无显著性。胰腺HE染色发现模型对照组胰腺有明显的炎性细胞浸润,而皮下注射给药组胰岛基本无浸润。与空白对照组和模型对照组比较,皮下注射给药组脾淋巴细胞增殖能力降低(P<0.05)。FACS显示皮下注射给药组CD4+CD2+5T细胞亚群比例明显高于空白对照组和模型对照组。结论皮下注射自身抗原胰岛素可以诱导免疫耐受防治糖尿病,其机制与促进体内CD4+CD2+5T细胞亚群产生相关。
张程亮蔡晓寒李秋彭佳蓓向明
关键词:胰岛素自身抗原免疫耐受
T细胞介导的1型糖尿病小鼠模型的建立及机制研究被引量:4
2006年
目的:建立T细胞介导的1型糖尿病(IDDM)小鼠模型。方法:BALB/c小鼠小剂量连续多次ip链脲佐菌素(STZ)制备1型糖尿病模型,4周后处死取脾制备脾细胞悬液建立T淋巴细胞系,并将不同数量T淋巴细胞过继转移到经不同方式预处理的BALB/c小鼠体内。符合高血糖诊断标准后处死动物,观察胰腺病理变化,检测脾淋巴细胞增殖反应。结果:2次ip小剂量STZ联合3×106T细胞过继转移,或采用2次ip环磷酰胺联合2次ip STZ和1.5×106T细胞过继转移,均可建立1型糖尿病动物模型。血糖分别于T细胞过继转移后第20和第13天显著升高(P<0.05),脾淋巴细胞增殖能力明显增强(P< 0.05),胰腺见大量淋巴细胞浸润和严重胰岛β细胞破坏。结论:BALB/c小鼠一次性过继转移IDDM发病T淋巴细胞可成功复制1型糖尿病模型。
邹晓蕾曹瑜袁思佑向明
关键词:T细胞免疫1型糖尿病动物模型
Dendritic cells and regulatory cells in autoantigen induced murine immune tolerance model
<正> Aim: To investigate the preventive effect of autoantigen insulin given subcuta-neously on IDDM murine mode...
Cheng- liang Zhang,Ming Xiang,Xiao - lei Zou,Xiao - han Cai,Jia - bei Peng
关键词:AUTOANTIGEN
文献传递
中药免疫调节剂对IDDM发病的干预及其机制研究
目的探讨蝙蝠蛾拟青霉人工发酵虫草Cs-4菌丝(PHC)体内干预IDDM发病的作用及机制。方法取健康雄性Balb/c小鼠,每天ip 40 mg/kg STZ溶液,连续5d,建立小鼠IDDM模型;在模型建立7 d前,分组ig...
向明汤静储潼张程亮
关键词:免疫调节剂人工虫草免疫抑制
文献传递
DIABETOGENIC T CELLS INDUCE AUTOIMMUNE DIABETES IN BALB/c MICE被引量:1
2008年
Objective To investigate the role of T cell and its subsets in the induction of insulitis and type 1 diabetes mellitus(T1DM)in BALB/c mice.Methods Autoimmune diabetes mellitus was developed by intraperitoneal injection of 40 mg/kg streptozotocin(STZ)daily for 5 consecutive days in BALB/c mice as sources of donor cells.Spleen cells from diabetic mice were then cultured for 7 days in the stimulation of interleukin-2(IL-2)to harvest diabetogenic T cells,which were subsequently transferred into normal BALB/c mice recipients.MTT,ELISA,and HE staining were used to analyze the lymphocyte proliferation,cytokine(IL-2,interferon-γ,IL-4,and IL-10)levels,and pathological changes in pancreatic islets.Results As few as 3×106 diabetogenic T cells successfully induced diabetes mellitus in recipients pretreated with STZ twice,whereas transfer of equal amount of normal splenocytes,T cell-depleted diabetogenic splenocytes,or diabetogenic CD4+ T cells alone in recipients receiving STZ twice pretreatment was proved not to induce diabetes mellitus either.A markedly increased lymphocyte proliferation,high levels of interferon-γ and IL-2 in the supernatants of diabetogenic T cells were observed.In addition,a markedly enhanced lymphocyte proliferation,a high level of interferon-γ secretion in serum,and numerous lymphocytes infiltration in pancreatic islets were detected in the diabetic mice induced by diabetogenic T cells transfer.Conclusions A novel T1DM murine model is established in STZ-pretreated BALB/c mice by adoptive transfer of diabetogenic T cells.CD4+ T cells with interferon-γ may promote the onset of diabetes mellitus.
Xiao-lei Zou Zeng-yu Zhao Yun-yang Wang Zhi-qiang Su Ming Xiang
关键词:糖尿病T细胞链脲霉素自体免疫
耐受性树突状细胞过继转移建立1型糖尿病小鼠感染性免疫耐受被引量:1
2007年
目的探讨耐受性树突状细胞(DC)过继转移,在T1DM模型小鼠体内建立感染性免疫耐受的方法和机制。方法在链脲佐菌素(STZ)所致1型糖尿病模型(type 1 diabetes mellitus,T1DM)内采用胰岛素与IEA混合乳剂皮下注射的方式诱导免疫耐受。体外分离和纯化耐受性树突状细胞。另取BALB/c小鼠,通过体内腹腔注射STZ,尾静脉注射T1DM发病小鼠脾脏T淋巴细胞(DTE),诱导T1DM。同时将不同来源DC经腹腔注射入模型小鼠体内。每周测定血糖,第4周时处死动物,取胰腺进行病理组织学检查。MTT法测定小鼠脾淋巴细胞增殖反应,采用流式细胞术检测CD4^+CD25^+调节性T细胞。结果采用2次小剂量STZ加DTL联合注射的方式可在小鼠体内建立以胰腺B细胞炎性破坏为主要病理特征的T1DM。通过过继转移免疫耐受性DC,可明显降低糖尿病高血糖以及小鼠脾淋巴细胞增殖能力,与模型对照组差异有统计学意义(P〈0.01);组织病理检查发现胰岛内炎症细胞浸润减少,组织结构完整;FACS显示CD4^+CD25^+T细胞亚群比例显著升高。结论过继转移耐受性Dc可以在次一级T1DM模型内诱导感染性免疫耐受并防止T1DM的发生,其机制与促进体内CD4^+CD25^+T细胞亚群产生相关。
张程亮邹晓蕾袁思佑曹瑜向明
关键词:树突状细胞1型糖尿病
Autoantigen administration confers diabetes-preventive properties to NOD mice derived dendritic cells
2007年
Administration of autoantigen can be of value for prevention of autoimmune diabetes and it has been speculated that the control point of dendritic cells(DC)for the induction of peripheral toler- ance may be highly relevant.We examined the properties of DC associated with immune suppression in NOD mice by insulin injection subcutaneously and their ability to suppress diabetes transfer by diabeto- genic effector cells in secondary NOD-SCID recipients.Our data showed that the surface expressions of MHCⅡand CD86 on NOD-derived DC were increased after insulin treatment compared with those on PBS controlled mice.The dendritic cells with a mature phenotype and increased MLR stimulation adop- tively transferred immune tolerogenic effects on secondary NOD-SCID mice,which were associated with significantly greater IL-10,TGF-beta production and CD4^+ CD25^+ T differentiation from splenocytes compared with NOD-SCID control recipients.Moreover,treatment with DC remarkably decreased the incidence of diabetes in secondary recipients.These results suggest that a subtype of DC generated by insulin subcutaneous treated NOD mice confers potential protection against diabetes through polarizing the immune response towards a Th2 regulatory pathway.
MING XIANG XIAO LEI ZOU JING XU YAO YAO JIN FANG ZHANG
关键词:自身抗原
共1页<1>
聚类工具0